AU2010319490B2 - Nutritional composition for promoting gut microbiota balance and health - Google Patents

Nutritional composition for promoting gut microbiota balance and health Download PDF

Info

Publication number
AU2010319490B2
AU2010319490B2 AU2010319490A AU2010319490A AU2010319490B2 AU 2010319490 B2 AU2010319490 B2 AU 2010319490B2 AU 2010319490 A AU2010319490 A AU 2010319490A AU 2010319490 A AU2010319490 A AU 2010319490A AU 2010319490 B2 AU2010319490 B2 AU 2010319490B2
Authority
AU
Australia
Prior art keywords
colon
nutritional composition
fos
fiber
blend
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Active
Application number
AU2010319490A
Other languages
English (en)
Other versions
AU2010319490A1 (en
Inventor
Jalil Benyacoub
Douglas Richard Bolster
Clara Lucia Garcia Rodenas
Norman Alan Greenberg
Jennifer Rae Mager
Florence Rochat
Claudia Roessle
Zamzam Fariba Roughead
Julie Ann Swanson
Current Assignee (The listed assignees may be inaccurate. Google has not performed a legal analysis and makes no representation or warranty as to the accuracy of the list.)
Societe des Produits Nestle SA
Original Assignee
Societe des Produits Nestle SA
Nestle SA
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Family has litigation
First worldwide family litigation filed litigation Critical https://patents.darts-ip.com/?family=43567734&utm_source=google_patent&utm_medium=platform_link&utm_campaign=public_patent_search&patent=AU2010319490(B2) "Global patent litigation dataset” by Darts-ip is licensed under a Creative Commons Attribution 4.0 International License.
Application filed by Societe des Produits Nestle SA, Nestle SA filed Critical Societe des Produits Nestle SA
Publication of AU2010319490A1 publication Critical patent/AU2010319490A1/en
Application granted granted Critical
Publication of AU2010319490B2 publication Critical patent/AU2010319490B2/en
Assigned to Société des Produits Nestlé S.A. reassignment Société des Produits Nestlé S.A. Request for Assignment Assignors: NESTEC S.A.
Active legal-status Critical Current
Anticipated expiration legal-status Critical

Links

Classifications

    • A—HUMAN NECESSITIES
    • A23—FOODS OR FOODSTUFFS; TREATMENT THEREOF, NOT COVERED BY OTHER CLASSES
    • A23L—FOODS, FOODSTUFFS OR NON-ALCOHOLIC BEVERAGES, NOT OTHERWISE PROVIDED FOR; PREPARATION OR TREATMENT THEREOF
    • A23L33/00—Modifying nutritive qualities of foods; Dietetic products; Preparation or treatment thereof
    • A23L33/20—Reducing nutritive value; Dietetic products with reduced nutritive value
    • A23L33/21—Addition of substantially indigestible substances, e.g. dietary fibres
    • A—HUMAN NECESSITIES
    • A23—FOODS OR FOODSTUFFS; TREATMENT THEREOF, NOT COVERED BY OTHER CLASSES
    • A23L—FOODS, FOODSTUFFS OR NON-ALCOHOLIC BEVERAGES, NOT OTHERWISE PROVIDED FOR; PREPARATION OR TREATMENT THEREOF
    • A23L29/00—Foods or foodstuffs containing additives; Preparation or treatment thereof
    • A23L29/20—Foods or foodstuffs containing additives; Preparation or treatment thereof containing gelling or thickening agents
    • A23L29/206—Foods or foodstuffs containing additives; Preparation or treatment thereof containing gelling or thickening agents of vegetable origin
    • A23L29/244—Foods or foodstuffs containing additives; Preparation or treatment thereof containing gelling or thickening agents of vegetable origin from corms, tubers or roots, e.g. glucomannan
    • A—HUMAN NECESSITIES
    • A23—FOODS OR FOODSTUFFS; TREATMENT THEREOF, NOT COVERED BY OTHER CLASSES
    • A23L—FOODS, FOODSTUFFS OR NON-ALCOHOLIC BEVERAGES, NOT OTHERWISE PROVIDED FOR; PREPARATION OR TREATMENT THEREOF
    • A23L29/00—Foods or foodstuffs containing additives; Preparation or treatment thereof
    • A23L29/20—Foods or foodstuffs containing additives; Preparation or treatment thereof containing gelling or thickening agents
    • A23L29/206—Foods or foodstuffs containing additives; Preparation or treatment thereof containing gelling or thickening agents of vegetable origin
    • A23L29/25—Exudates, e.g. gum arabic, gum acacia, gum karaya or tragacanth
    • A—HUMAN NECESSITIES
    • A23—FOODS OR FOODSTUFFS; TREATMENT THEREOF, NOT COVERED BY OTHER CLASSES
    • A23L—FOODS, FOODSTUFFS OR NON-ALCOHOLIC BEVERAGES, NOT OTHERWISE PROVIDED FOR; PREPARATION OR TREATMENT THEREOF
    • A23L33/00—Modifying nutritive qualities of foods; Dietetic products; Preparation or treatment thereof
    • A23L33/10—Modifying nutritive qualities of foods; Dietetic products; Preparation or treatment thereof using additives
    • A—HUMAN NECESSITIES
    • A23—FOODS OR FOODSTUFFS; TREATMENT THEREOF, NOT COVERED BY OTHER CLASSES
    • A23L—FOODS, FOODSTUFFS OR NON-ALCOHOLIC BEVERAGES, NOT OTHERWISE PROVIDED FOR; PREPARATION OR TREATMENT THEREOF
    • A23L33/00—Modifying nutritive qualities of foods; Dietetic products; Preparation or treatment thereof
    • A23L33/40—Complete food formulations for specific consumer groups or specific purposes, e.g. infant formula
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/70—Carbohydrates; Sugars; Derivatives thereof
    • A61K31/702—Oligosaccharides, i.e. having three to five saccharide radicals attached to each other by glycosidic linkages
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/70—Carbohydrates; Sugars; Derivatives thereof
    • A61K31/715—Polysaccharides, i.e. having more than five saccharide radicals attached to each other by glycosidic linkages; Derivatives thereof, e.g. ethers, esters
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K38/00—Medicinal preparations containing peptides
    • A61K38/16—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof
    • A61K38/17—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans
    • A61K38/22—Hormones
    • A61K38/28—Insulins
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P1/00—Drugs for disorders of the alimentary tract or the digestive system
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P1/00—Drugs for disorders of the alimentary tract or the digestive system
    • A61P1/04—Drugs for disorders of the alimentary tract or the digestive system for ulcers, gastritis or reflux esophagitis, e.g. antacids, inhibitors of acid secretion, mucosal protectants
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P1/00—Drugs for disorders of the alimentary tract or the digestive system
    • A61P1/08—Drugs for disorders of the alimentary tract or the digestive system for nausea, cinetosis or vertigo; Antiemetics
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P1/00—Drugs for disorders of the alimentary tract or the digestive system
    • A61P1/10—Laxatives
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P1/00—Drugs for disorders of the alimentary tract or the digestive system
    • A61P1/12—Antidiarrhoeals
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P11/00—Drugs for disorders of the respiratory system
    • A61P11/06—Antiasthmatics
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P19/00—Drugs for skeletal disorders
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P19/00—Drugs for skeletal disorders
    • A61P19/08—Drugs for skeletal disorders for bone diseases, e.g. rachitism, Paget's disease
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P21/00—Drugs for disorders of the muscular or neuromuscular system
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P25/00—Drugs for disorders of the nervous system
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P25/00—Drugs for disorders of the nervous system
    • A61P25/20—Hypnotics; Sedatives
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P25/00—Drugs for disorders of the nervous system
    • A61P25/24—Antidepressants
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P25/00—Drugs for disorders of the nervous system
    • A61P25/28—Drugs for disorders of the nervous system for treating neurodegenerative disorders of the central nervous system, e.g. nootropic agents, cognition enhancers, drugs for treating Alzheimer's disease or other forms of dementia
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P27/00—Drugs for disorders of the senses
    • A61P27/16—Otologicals
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P29/00—Non-central analgesic, antipyretic or antiinflammatory agents, e.g. antirheumatic agents; Non-steroidal antiinflammatory drugs [NSAID]
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P3/00—Drugs for disorders of the metabolism
    • A61P3/02—Nutrients, e.g. vitamins, minerals
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P37/00—Drugs for immunological or allergic disorders
    • A61P37/02—Immunomodulators
    • A61P37/04—Immunostimulants
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P37/00—Drugs for immunological or allergic disorders
    • A61P37/02—Immunomodulators
    • A61P37/06—Immunosuppressants, e.g. drugs for graft rejection
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P43/00—Drugs for specific purposes, not provided for in groups A61P1/00-A61P41/00
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P5/00—Drugs for disorders of the endocrine system
    • A—HUMAN NECESSITIES
    • A23—FOODS OR FOODSTUFFS; TREATMENT THEREOF, NOT COVERED BY OTHER CLASSES
    • A23V—INDEXING SCHEME RELATING TO FOODS, FOODSTUFFS OR NON-ALCOHOLIC BEVERAGES AND LACTIC OR PROPIONIC ACID BACTERIA USED IN FOODSTUFFS OR FOOD PREPARATION
    • A23V2002/00—Food compositions, function of food ingredients or processes for food or foodstuffs

Landscapes

  • Health & Medical Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Engineering & Computer Science (AREA)
  • Medicinal Chemistry (AREA)
  • Veterinary Medicine (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Animal Behavior & Ethology (AREA)
  • General Health & Medical Sciences (AREA)
  • Public Health (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • General Chemical & Material Sciences (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Organic Chemistry (AREA)
  • Nutrition Science (AREA)
  • Polymers & Plastics (AREA)
  • Food Science & Technology (AREA)
  • Mycology (AREA)
  • Immunology (AREA)
  • Epidemiology (AREA)
  • Dispersion Chemistry (AREA)
  • Neurology (AREA)
  • Biomedical Technology (AREA)
  • Neurosurgery (AREA)
  • Molecular Biology (AREA)
  • Diabetes (AREA)
  • Physical Education & Sports Medicine (AREA)
  • Endocrinology (AREA)
  • Pediatric Medicine (AREA)
  • Zoology (AREA)
  • Gastroenterology & Hepatology (AREA)
  • Proteomics, Peptides & Aminoacids (AREA)
  • Pulmonology (AREA)
  • Pain & Pain Management (AREA)
  • Orthopedic Medicine & Surgery (AREA)
  • Rheumatology (AREA)
  • Hospice & Palliative Care (AREA)
  • Psychiatry (AREA)
  • Obesity (AREA)
AU2010319490A 2009-11-12 2010-11-11 Nutritional composition for promoting gut microbiota balance and health Active AU2010319490B2 (en)

Applications Claiming Priority (7)

Application Number Priority Date Filing Date Title
US26049509P 2009-11-12 2009-11-12
US61/260,495 2009-11-12
US26443009P 2009-11-25 2009-11-25
US61/264,430 2009-11-25
US39480510P 2010-10-20 2010-10-20
US61/394,805 2010-10-20
PCT/US2010/056321 WO2011060123A1 (en) 2009-11-12 2010-11-11 Nutritional composition for promoting gut microbiota balance and health

Publications (2)

Publication Number Publication Date
AU2010319490A1 AU2010319490A1 (en) 2012-05-03
AU2010319490B2 true AU2010319490B2 (en) 2015-03-19

Family

ID=43567734

Family Applications (1)

Application Number Title Priority Date Filing Date
AU2010319490A Active AU2010319490B2 (en) 2009-11-12 2010-11-11 Nutritional composition for promoting gut microbiota balance and health

Country Status (14)

Country Link
US (2) US9192179B2 (enExample)
EP (1) EP2498626B1 (enExample)
JP (2) JP6006117B2 (enExample)
CN (2) CN104206946A (enExample)
AU (1) AU2010319490B2 (enExample)
BR (1) BR112012011294B1 (enExample)
CA (1) CA2777941C (enExample)
DK (1) DK2498626T3 (enExample)
ES (1) ES2545597T3 (enExample)
IN (1) IN2012DN03632A (enExample)
MX (1) MX336032B (enExample)
PH (1) PH12012500687A1 (enExample)
RU (1) RU2012123959A (enExample)
WO (1) WO2011060123A1 (enExample)

Families Citing this family (90)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
PH12012500687A1 (en) * 2009-11-12 2012-10-29 Nestec Sa Nutritional composition for promoting gut microbiota balance and health
NZ612455A (en) * 2010-12-31 2015-02-27 Abbott Lab Human milk oligosaccharides to promote growth of beneficial bacteria
WO2012177556A2 (en) 2011-06-20 2012-12-27 H.J. Heinz Company Probiotic compositions and methods
WO2012175639A1 (en) * 2011-06-22 2012-12-27 Universite De Rouen Arabinogalactan proteins for use as an antiparasitic agent
FI126711B (fi) * 2011-10-12 2017-04-13 Gut Guide Oy Serotoniinivajeeseen liittyvän terveysriskin arvioiminen
PH12014500558A1 (en) 2011-10-18 2014-04-14 Nestec Sa Composition for use in the promotion of healthy bone growth and/or in the prevention and/or treatment of bone disease
TW201318566A (zh) * 2011-11-01 2013-05-16 呂健民 膳食補充劑組合物及其用於調控血糖之方法
IN2014DN07752A (enExample) 2012-02-29 2015-05-15 Ethicon Endo Surgery Inc
ITRM20120084A1 (it) 2012-03-07 2013-09-08 Aboca Spa Societa Agricola Miscela prebiotica.
WO2014007606A1 (en) 2012-07-05 2014-01-09 N.V. Nutricia Product for use in the prophylactic or therapeutic treatment of a negative emotion or introvert behaviour
US20150283144A1 (en) * 2012-11-01 2015-10-08 Rijksuniversiteit Groningen Methods and compositions for stimulating beneficial bacteria in the gastrointestinal tract
US8906668B2 (en) 2012-11-23 2014-12-09 Seres Health, Inc. Synergistic bacterial compositions and methods of production and use thereof
CN104955466A (zh) 2012-11-23 2015-09-30 赛里斯治疗公司 协同细菌组合物和其制造方法和用途
US20150296851A1 (en) * 2012-11-27 2015-10-22 Shanghai Jiao Tong University Compositions for Balancing Gut Microbiota and the Preparation and the Uses thereof
WO2014121304A1 (en) 2013-02-04 2014-08-07 Seres Health, Inc. Compositions and methods
KR102222273B1 (ko) * 2013-02-04 2021-03-08 세레스 테라퓨틱스, 인코포레이티드 조성물 및 방법
WO2014145958A2 (en) 2013-03-15 2014-09-18 Seres Health, Inc. Network-based microbial compositions and methods
HK1218715A1 (zh) * 2013-03-15 2017-03-10 Microbiome Therapeutics, Llc. 活化的大豆豆荚纤维
GB201312713D0 (en) * 2013-03-22 2013-08-28 Weaver Connie M Uses of soluble corn fibre for increasing colonic bacteria populations and increasing mineral absorption
GB201305708D0 (en) * 2013-03-28 2013-05-15 Clasado Inc Novel use
WO2014165975A1 (en) * 2013-04-11 2014-10-16 Bright Drinks Inc. Compositions for prevention and/or treatment of gastrointestinal imbalances in digestive disorders
ITMI20131467A1 (it) * 2013-09-06 2015-03-07 Sofar Spa Uso di una composizione comprendente microrganismi per aumentare la produzione intestinale di acido butirrico, di acido folico o di niacina e/o per diminuire la produzione intestinale di acido succinico
EP3074027B1 (en) 2013-11-25 2024-12-18 Seres Therapeutics, Inc. Synergistic bacterial compositions and methods of production and use thereof
EP3082431A4 (en) 2013-12-16 2017-11-15 Seres Therapeutics, Inc. Bacterial compositions and methods of use thereof for treatment of immune system disorders
US9943559B2 (en) * 2013-12-20 2018-04-17 Nestec S.A. Nutritional compositions for reducing intestinal pathogens
MA39710A (fr) 2014-04-23 2015-10-29 Sofar Spa Composition topique destinée à être utilisée dans le traitement d'une maladie inflammatoire de l'intestin
CN104187624B (zh) * 2014-08-07 2016-06-08 逯明福 综合营养粉及其制备方法
WO2016029113A1 (en) * 2014-08-22 2016-02-25 Abbott Laboratories Methods of increasing endogenous production of beta-hydroxy-beta-methylbutyrate
KR101814967B1 (ko) 2014-09-30 2018-01-04 킴벌리-클라크 월드와이드, 인크. 크레이프된 프리바이오틱 티슈
EP3200766B1 (en) 2014-09-30 2019-07-03 Kimberly-Clark Worldwide, Inc. Synergistic prebiotic composition
SG10201903823QA (en) 2014-10-31 2019-05-30 Whole Biome Inc Methods and compositions relating to microbial treatment and diagnosis of disorders
CN104432069A (zh) * 2014-12-22 2015-03-25 威海百合生物技术股份有限公司 一种肠胃通畅片
JP6338113B2 (ja) * 2015-03-31 2018-06-06 株式会社東洋新薬 除脂肪体重の増加剤
EP3397960B1 (en) * 2015-12-30 2020-01-29 Société des Produits Nestlé S.A. Method for determining fat free body mass
WO2017114733A1 (en) * 2015-12-31 2017-07-06 Nestec S.A. Composition for improving mouthfeel
ES2960781T3 (es) * 2016-02-04 2024-03-06 Univ Gent Uso de comunidades microbianas para la salud humana y animal
EP3445857B1 (en) 2016-04-20 2023-07-05 The Board of Trustees of the Leland Stanford Junior University Compositions and methods for nucleic acid expression and protein secretion in bacteroides
MA45327A (fr) 2016-05-13 2019-03-20 Sofar Spa Utilisation de probiotiques pour améliorer l'absorption des protéines
MA45288A (fr) 2016-06-08 2019-04-17 Sofar Spa Nouvelle utilisation médicale de probiotiques
US20180030403A1 (en) 2016-07-28 2018-02-01 Bobban Subhadra Devices, systems and methods for the production of humanized gut commensal microbiota
US20200016256A1 (en) * 2016-09-22 2020-01-16 The University Of Chicago Immune response modulation using live biotherapeutics, for conditions such as allergy desensitization
IT201600122724A1 (it) 2016-12-02 2018-06-02 Sofar Spa Exopolysaccharides and uses thereof
WO2018112194A1 (en) 2016-12-15 2018-06-21 The Board Of Trustees Of The Leland Stanford Junior University Compositions and methods for modulating growth of a genetically modified gut bacterial cell
IT201600127498A1 (it) 2016-12-16 2018-06-16 Sofar Spa Probiotici per uso nella diverticolosi e malattia diverticolare
CN108245530A (zh) * 2016-12-28 2018-07-06 兰州奇正生态健康品有限公司 一种具有润肠通便作用的组合物及其制备方法与用途
ES2683014B1 (es) * 2017-03-23 2019-01-16 Cuetara S L Galleta infantil sin azúcares añadidos
US11260088B2 (en) 2017-06-21 2022-03-01 Abbott Laboratories Methods for increasing growth of beneficial bacteria in the gastrointestinal tract
BR112020002992A2 (pt) 2017-08-14 2020-08-18 Seres Therapeutics, Inc. composições e métodos para tratamento de doença colestática
WO2019046646A1 (en) 2017-08-30 2019-03-07 Whole Biome Inc. METHODS AND COMPOSITIONS FOR THE TREATMENT OF MICROBIOMA ASSOCIATED DISORDERS
GB2566971B (en) * 2017-09-28 2020-12-02 Mjn Us Holdings Llc Infant formula having decreased protein content
IT201700108033A1 (it) 2017-09-27 2019-03-27 Neilos S R L Composizione per il trattamento della costipazione
IT201700108039A1 (it) 2017-09-27 2019-03-27 Neilos S R L Composizione per il trattamento della costipazione
EP3466276A1 (en) 2017-10-05 2019-04-10 Pharmactive Biotech Products, S.L. Dietary fiber composition for protecting bioactive compounds during the physiological digestion process
CA3080586A1 (en) 2017-10-30 2019-05-09 Seres Therapeutics, Inc. Compositions and methods for treating antibiotic resistance
WO2019087280A1 (ja) * 2017-10-31 2019-05-09 森永乳業株式会社 筋肉増量用組成物
US11484547B2 (en) * 2018-01-08 2022-11-01 Performance Labs PTE. LTD. Compositions and methods for cholesterol, glucose and microbiome control
CN113164526A (zh) 2018-07-19 2021-07-23 潘德勒姆治疗公司 用于微生物植入的方法和组合物
US20200113858A1 (en) 2018-10-15 2020-04-16 Freedom Health, Llc Human dietary supplement and method for treating digestive system and immune-related disorders
AU2019410086B2 (en) * 2018-12-19 2025-04-17 Cosucra Groupe Warcoing S.A. Composition comprising chicory root and pea cell wall fiber for treating Brachyspira infections
US11622974B2 (en) 2019-01-18 2023-04-11 C.P. Kelco U.S., Inc. Prebiotic composition and its use
WO2020161522A1 (en) * 2019-02-06 2020-08-13 Thd S.P.A. Fiber-based composition
FR3093427B1 (fr) * 2019-03-05 2021-03-05 Mativa Tech Composition pour son utilisation dans la prévention et/ou le traitement de la dysbiose
WO2020185857A1 (en) * 2019-03-12 2020-09-17 The Board Of Regents Of The University Of Texas System Simultaneous blood glucose monitoring and gastric emptying scintigraphy
CN109820865A (zh) * 2019-04-09 2019-05-31 福州大学 低聚木糖和部分水解的瓜尔豆胶复配组合物在预防肥胖及保健品中的应用
JP7321503B2 (ja) * 2019-05-21 2023-08-07 フジ日本精糖株式会社 イヌリンを含む筋肉量減少抑制又は骨密度減少抑制剤
CN114072013A (zh) 2019-05-29 2022-02-18 N·V·努特里奇亚 用于降低结肠蛋白发酵的非消化性寡糖
CN110251530A (zh) * 2019-07-09 2019-09-20 大连大学 一种落叶松阿拉伯半乳聚糖组合物的制备方法及其临床应用
CN114341363A (zh) * 2019-08-30 2022-04-12 Hem制药股份有限公司 使用pmas方法的个体化定制型肠道环境改善物质筛选方法
GB201915144D0 (en) * 2019-10-18 2019-12-04 Multigerm Uk Entpr Ltd Method of promoting SCFA production by gut microbiota
US11751597B2 (en) 2019-11-05 2023-09-12 Alfasigma S.P.A. Compositions comprising bacterial strains for use in increasing the bioavailability of amino acids derived from proteins, and related food product methods and systems
CN110679955A (zh) * 2019-11-11 2020-01-14 成都高新区九州华昀医疗美容门诊部有限公司 可改善肠道功能的大鲵活性肽营养组合物
PH12022552279A1 (en) * 2020-02-27 2024-01-29 Abbott Lab Methods of improving bone health
BR112022019018A2 (pt) * 2020-04-24 2022-11-01 Nestle Sa Composição que compreende fibra e amora
CN111440841A (zh) * 2020-05-19 2020-07-24 爱礼康生物医药（苏州）有限公司 一种检测膳食纤维对人肠道菌活性影响的方法
WO2021233925A1 (en) * 2020-05-20 2021-11-25 Société des Produits Nestlé S.A. Beneficial effect of poaceae and/or leguminoseae fiber on survivability and metabolic activity of bifidobacterium longum
CA3178133A1 (en) * 2020-05-29 2021-12-02 Julie K SPEARS Compositions and methods for digestive health in an animal
JP7688866B2 (ja) * 2020-07-14 2025-06-05 物産フードサイエンス株式会社 筋肉量率を増加させる剤および方法、ならびに体脂肪率を減少させる剤および方法
WO2022083858A1 (en) * 2020-10-21 2022-04-28 Compagnie Gervais Danone Acacia gum for iron induced microbial dysbiosis
JP2022072243A (ja) * 2020-10-29 2022-05-17 帝人株式会社 腸内細菌叢改善用組成物及び腸内腐敗物質産生抑制用組成物
CN112715669A (zh) * 2020-11-24 2021-04-30 本溪木兰花乳业有限责任公司 一种改善便秘的牛奶制品及其制备方法
WO2022122958A1 (en) 2020-12-09 2022-06-16 N.V. Nutricia Fibre mixture for young children
EP4119135A1 (fr) * 2021-07-13 2023-01-18 Luxia Scientific Methodes pour reequilibrer la flore intestinale chez les patients souffrant de la maladie de parkinson
US20240366654A1 (en) * 2021-07-16 2024-11-07 Purdue Research Foundation Prebiotic composition and method of use to improve gastrointestinal health in patients with dysbiosis and leaky gut
CN113826892A (zh) * 2021-09-17 2021-12-24 潍坊易北特健康食品有限公司 一种基于肠道微生物调控特定胆汁酸的组合物及制备方法
WO2023054625A1 (ja) * 2021-09-29 2023-04-06 森永乳業株式会社 トレオン酸含有組成物及びその製造方法
CN114224925A (zh) * 2021-12-23 2022-03-25 广东格物生物科技有限公司 一种调节肠道健康的益生菌组合物及其制备方法
ES2955633A1 (es) * 2022-04-26 2023-12-04 Servicio Andaluz De Salud Composición para la rehabilitación intestinal
CN115025116B (zh) * 2022-07-13 2023-11-21 纽湃腾（北京）医药科技有限公司 一种显著改善胃食管反流伴肠易激综合征的组合物及其应用
WO2025106584A1 (en) * 2023-11-14 2025-05-22 Kate Farms, Inc. Infant formula
GR1011003B (el) * 2024-02-28 2025-07-22 Cloudpharm Private Company, Συμπληρωμα διατροφης για την αντιμετωπιση της απωλειας της οστικης πυκνοτητας (οστεοπενια)

Citations (1)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US20030040492A1 (en) * 2000-03-01 2003-02-27 Ferdinand Haschke Carbohydrate formulation (prebiotic adjuvant) for enhancement of immune response

Family Cites Families (18)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US5952314A (en) 1994-04-01 1999-09-14 Demichele; Stephen Joseph Nutritional product for a person having ulcerative colitis
ES2123903T5 (es) 1995-08-04 2011-02-22 N.V. Nutricia Composición nutritiva conteniendo fibra.
ATE308254T1 (de) 1998-12-15 2005-11-15 Nestle Sa Ballaststoffemischung für enterale zusammensetzung
EP1175905A1 (en) 2000-07-24 2002-01-30 Societe Des Produits Nestle S.A. Nutritional Composition
US20020044988A1 (en) * 2000-08-22 2002-04-18 Fuchs Eileen C. Nutritional composition and method for improving protein deposition
EP1243273A1 (en) 2001-03-22 2002-09-25 Societe Des Produits Nestle S.A. Composition comprising a prebiotic for decreasing infammatory process and abnormal activation of non-specific immune parameters
GB0308104D0 (en) 2003-04-08 2003-05-14 Novartis Nutrition Ag Organic compounds
ITMI20040956A1 (it) 2004-05-12 2004-08-12 Curti Alessandro Composizioni alimentari
EP1597978A1 (en) 2004-05-17 2005-11-23 Nutricia N.V. Synergism of GOS and polyfructose
US8252769B2 (en) 2004-06-22 2012-08-28 N. V. Nutricia Intestinal barrier integrity
ES2334943T3 (es) 2005-10-05 2010-03-17 Nestec S.A. Uso de una formulacion nutritiva para fomentar la recuperacion del crecimiento.
ITMI20062031A1 (it) * 2006-10-23 2008-04-24 Velleja Res Srl Composizioni per la prevenzione del depauperamento della flora intestinale e del danno d'organo successivi a terapia antibiotica
CN101534656B (zh) 2006-11-07 2013-05-22 宝洁公司 包含纤维的组合物及其制备和使用方法
ITMI20071214A1 (it) * 2007-06-15 2008-12-16 S I I T Srl Servizio Internazi Composizioni a base di componenti prebiotici ed immunogenici per la prevenzione e il trattamento di disturbi gastroenterici da disbiosi e/o alterazioni della normale flora intestinale
PL2178385T5 (pl) 2007-07-18 2024-10-21 Frieslandcampina Nederland Holding B.V. Termostabilny napój odżywczy i sposób jego wytwarzania
WO2009075564A1 (en) 2007-12-10 2009-06-18 N.V. Nutricia Paediatric fibre mixture
JP5992654B2 (ja) 2007-12-21 2016-09-14 ニュートリー株式会社 整腸及び／又は便通改善のための組成物
PH12012500687A1 (en) * 2009-11-12 2012-10-29 Nestec Sa Nutritional composition for promoting gut microbiota balance and health

Patent Citations (1)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US20030040492A1 (en) * 2000-03-01 2003-02-27 Ferdinand Haschke Carbohydrate formulation (prebiotic adjuvant) for enhancement of immune response

Non-Patent Citations (1)

* Cited by examiner, † Cited by third party
Title
MACFARLANE G.T. et al. J. Appl. Microbiol. vol. 104, 2008, pp. 305-344. *

Also Published As

Publication number Publication date
US20160100617A1 (en) 2016-04-14
JP2016166176A (ja) 2016-09-15
JP6006117B2 (ja) 2016-10-12
CA2777941C (en) 2018-08-14
WO2011060123A1 (en) 2011-05-19
PH12012500687A1 (en) 2012-10-29
US9192179B2 (en) 2015-11-24
CA2777941A1 (en) 2011-05-19
EP2498626A1 (en) 2012-09-19
JP2013510865A (ja) 2013-03-28
CN102595934A (zh) 2012-07-18
US20120269865A1 (en) 2012-10-25
JP6205003B2 (ja) 2017-09-27
IN2012DN03632A (enExample) 2015-06-26
DK2498626T3 (en) 2015-07-13
EP2498626B1 (en) 2015-06-17
BR112012011294B1 (pt) 2018-03-20
BR112012011294A2 (pt) 2015-09-15
MX336032B (es) 2016-01-07
RU2012123959A (ru) 2013-12-20
HK1172516A1 (en) 2013-04-26
ES2545597T3 (es) 2015-09-14
AU2010319490A1 (en) 2012-05-03
CN104206946A (zh) 2014-12-17
MX2012004778A (es) 2012-06-01
US10015978B2 (en) 2018-07-10

Similar Documents

Publication Publication Date Title
AU2010319490B2 (en) Nutritional composition for promoting gut microbiota balance and health
US12290492B2 (en) Extensional viscosity to promote safe swallowing of food boluses
CN102573517B (zh) 稳定的增稠剂制品
AU2012351533B2 (en) Extensional viscosity to promote safe swallowing of food boluses
CN105828641A (zh) 用于减少肠病原体的营养组合物
US20160192686A1 (en) Cohesive liquid bolus comprising molecules providing visco-elasticity
HK1172516B (en) Nutritional composition for promoting gut microbiota balance and health

Legal Events

Date Code Title Description
FGA Letters patent sealed or granted (standard patent)
PC Assignment registered

Owner name: SOCIETE DES PRODUITS NESTLE S.A.

Free format text: FORMER OWNER(S): NESTEC S.A.